Tengjun Biotechnology Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tengjun Biotechnology Corp. generated cash of $1,347,451, which is more than the previous year. Cash used in financing activities reached the amount of $1,776,551 last year. Net change in cash is therefore $2,545,078.
Cash Flow
| 2013 | -20K | 13K | 52.14K |
|---|---|---|---|
| 2014 | -99.79K | 0 | 69.77K |
| 2015 | -64.29K | 0 | 63.97K |
| 2016 | -44.16K | 0 | 42.37K |
| 2017 | -31.81K | 0 | 31.81K |
| 2018 | -30.44K | 0 | 30.44K |
| 2019 | -39.79K | 0 | 39.79K |
| 2020 | -31.76K | -181.53K | 37.70K |
| 2021 | -561.29K | -20.59K | 860.71K |
| 2022 | 1.34M | -503.80K | 1.77M |
TJBH Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 285.56K | 6.23K | 68.75K | 0 | 0 | 0 | 1.79K | 2.12K | 32.14K | 0 |
Operating activities | ||||||||||
Net income | 11.34M | -747.52K | -53.86K | -59.86K | -47.80K | -48.23K | -60.66K | -74.70K | -108.36K | -21.31K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 308.88K | 318.44K | 273.10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 456 | 5.88K | 317.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 1.84M | -217.53K | -317.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 5.44M | 507 | 511 | 0 | 125 | -361 | 7.02K | 494 | 3.39K | 450 |
Cash generated by operating activities | 1.34M | -561.29K | -31.76K | -39.79K | -30.44K | -31.81K | -44.16K | -64.29K | -99.79K | -20K |
Investing activities | ||||||||||
Purchases Of Investments | -520.70K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5.93K | -310.17K | -181.53K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 289.57K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -503.80K | -20.59K | -181.53K | 0 | 0 | 0 | 0 | 0 | 0 | 13K |
Financing activities | ||||||||||
Common Stock Issued | 5.55M | 0 | 29.41K | 5K | 0 | 19.30K | 1.05K | 0 | 0 | 32.14K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -2.93K | 0 | 0 | 0 | 0 | -10.75K |
Repayments of term debt | -47.03M | -852.96K | -29.41K | 34.79K | 0 | 9.57K | 0 | 63.97K | 0 | 0 |
Cash used in financing activities | 1.77M | 860.71K | 37.70K | 39.79K | 30.44K | 31.81K | 42.37K | 63.97K | 69.77K | 52.14K |
Net Change In Cash | 2.54M | 279.33K | -62.80K | 0 | 0 | 0 | -1.79K | -327 | -30.02K | 32.14K |
Cash at end of period | 2.83M | 285.56K | 5.94K | 0 | 0 | 0 | 0 | 1.79K | 2.12K | 32.14K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |